Option Care Health, Inc.
NASDAQ:OPCHMedical - Care Facilities
+$0.45 today
- Market cap
- $4.75B
- Beta
- 0.65
- P/E (TTM)
- 16.8
- EPS (TTM)
- $1.32
Volume 3.16M
Average 3.09M
OPCH EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Option Care Health, Inc.NASDAQ: OPCH
EPS (Diluted) · Q3 FY2026 · quarter ended Sep 2026
EPS (Diluted) growth accelerates
Q3 FY2026 EPS (Diluted) of $0.38 rose 18.8% year over year, ahead of the +10.3% change in trailing-twelve-month EPS (Diluted). Sequentially, it rose 8.6% from the prior quarter. Over 3 fiscal years it compounded at +15.2% a year.
Context
- EPS (Diluted) increased in 2 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 6 analysts of $1.88 (+48.1%) for the fiscal year ending Dec 2026, a step up from the +3.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $0.38+8.6% QoQ
- Last fiscal yearDec 2025
- $1.27+3.3% YoY
- LTMSep 2026
- $1.39+10.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +18.8% | +46.7% | +28.0 pp |
| 1 year | +3.3% | +48.1% | +44.8 pp |
| 3-year CAGR | +15.2% | +22.5% | +7.3 pp |
| 5-year CAGR | +17.0% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 1.27 USD
- Year-over-year change
- +3.3%
- 4-year CAGR
- +13.3%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.27 | +3.3% |
| FY2024 | 2024-12-31 | 1.23 | -16.9% |
| FY2023 | 2023-12-31 | 1.48 | +78.3% |
| FY2022 | 2022-12-31 | 0.83 | +7.8% |
| FY2021 | 2021-12-31 | 0.77 | — |
EPS (Diluted) vs competitors
How OPCH compares with its peers on the latest reported figures
- OPCH's LTM Sep 2026 EPS (Diluted) of $1.39 is the 5th highest of the 6 companies compared; the peer median is $6.14.
- Its year-over-year change of +10.3% is the 5th highest of 6, against a peer median of +15.8%.
- Over three fiscal years its annual growth of +15.2% compares with a peer median of +20.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $19.92 | +2.3% | +3.7% | |
| LTM Jun 2026 | $6.38 | +15.8% | +13.9% | |
| LTM Jun 2026 | $6.14 | +20.2% | +27.1% | |
| LTM Oct 2026 | $1.4 | +290.5% | — | |
| LTM Sep 2026 | $1.39 | +10.3% | +15.2% | |
| LTM Mar 2026 | $0.85 | +11.8% | +56.3% | |
| Peer median (excluding OPCH) | $6.14 | +15.8% | +20.5% | |
Competitors are the stored peer set for OPCH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 3.44B | 3.94B | 4.3B | 5B | 5.65B |
| Cost of Revenue | 2.66B | 3.08B | 3.32B | 3.99B | 4.63B |
| Gross Profit | 779.61M | 866.92M | 981.22M | 1.01B | 1.02B |
| Gross Margin | 22.7% | 22.0% | 22.8% | 20.3% | 18.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 525.71M | 566.12M | 607.43M | 630.25M | 682.45M |
| Operating Expenses | 588.77M | 626.69M | 666.63M | 691.16M | 682.45M |
| Depreciation & Amortization | 68.8M | 65.43M | 62.2M | 63.5M | 70.69M |
| EBITDA | 252.3M | 325.01M | 472.19M | 396.13M | 416.79M |
| EBITDA Margin | 7.3% | 8.2% | 11.0% | 7.9% | 7.4% |
| Operating Income | 190.84M | 240.23M | 314.6M | 321.83M | 337.91M |
| Operating Margin | 5.5% | 6.1% | 7.3% | 6.4% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 55.46M | 54.9M | 62.22M | 60.56M | 63.2M |
| Other Income / Expenses | (74.35M) | (34.46M) | 44.15M | (38.23M) | (55.01M) |
| Income Before Tax | 116.49M | 205.77M | 358.74M | 283.6M | 282.9M |
| Pre-Tax Margin | 3.4% | 5.2% | 8.3% | 5.7% | 5.0% |
| Income Tax Expense | (23.4M) | 55.21M | 91.65M | 71.78M | 75.32M |
| Net Income | 139.9M | 150.56M | 267.09M | 211.82M | 207.59M |
| Net Margin | 4.1% | 3.8% | 6.2% | 4.2% | 3.7% |
| EPS (Basic) | 0.78 | 0.83 | 1.49 | 1.23 | 1.28 |
| EPS (Diluted) | 0.77 | 0.83 | 1.48 | 1.23 | 1.27 |
| Weighted Avg Shares | 179.86M | 181.11M | 178.97M | 171.57M | 162.1M |
| Weighted Avg Shares (Diluted) | 181.21M | 182.08M | 180.38M | 172.85M | 163.37M |
Option Care Health, Inc.
NASDAQ:OPCH
Intrinsic Alpha fair value
Locked
Current Price
$31.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.